Introduction: Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by progressive degeneration of the motor neurons. It is difficult to define the severity of the clinical findings of this destructive disease owing to its rapid progression, which presents serious alterations in a short time even in the same patient. The present study was designed to evaulate the validity of the Turkish version of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), which has been used in various countries for measuring the functional status of ALS patients. Methods: The ALSFRS-R scores of 41 ALS patients (24 male), in any stages of illness, were simultaneously assessed by two physicians. The functional status of the ...
OBJECTIVES: To evaluate the validity and reliability of the amyotrophic lateral sclerosis assessme...
<p>Our objective was to examine dimensionality and item-level performance of the Amyotrophic Lateral...
Cognitive and behavioral impairment is observed in up to 50% of patients with amyotrophic lateral sc...
WOS: 000383254700007PubMed ID: 28373799Introduction: Amyotrophic lateral sclerosis (ALS) is a fatal ...
Background: The Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) is a quanti...
The amyotrophic lateral sclerosis functional rating scale-revised (ALSFRS-R) is a widely used primar...
International audienceAmyotrophic lateral sclerosis (ALS) is a progressive degeneration of the perip...
Aim The aim of this study was to investigate the validity and reliability of the Turkish version of ...
Very few studies examined trend over time of the revised Amyotrophic Lateral Sclerosis Functional Ra...
There is a need of standardized and quantitative clinical assessments of ALS patients receiving new ...
Our objective was to verify and expand previous evidence of psychometric inadequacies in the ALSFRS-...
<p>Numbers are mean ± standard deviation (range) or number. °Disease progression rate = (48-ALSFRS-r...
Contains fulltext : 50613.pdf (publisher's version ) (Closed access)It is importan...
The measurement of functioning and well-being from the perspective of the patient has in recent year...
Objective: The aim of the study was to investigate the incidence and prevalence of amyotrophic later...
OBJECTIVES: To evaluate the validity and reliability of the amyotrophic lateral sclerosis assessme...
<p>Our objective was to examine dimensionality and item-level performance of the Amyotrophic Lateral...
Cognitive and behavioral impairment is observed in up to 50% of patients with amyotrophic lateral sc...
WOS: 000383254700007PubMed ID: 28373799Introduction: Amyotrophic lateral sclerosis (ALS) is a fatal ...
Background: The Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) is a quanti...
The amyotrophic lateral sclerosis functional rating scale-revised (ALSFRS-R) is a widely used primar...
International audienceAmyotrophic lateral sclerosis (ALS) is a progressive degeneration of the perip...
Aim The aim of this study was to investigate the validity and reliability of the Turkish version of ...
Very few studies examined trend over time of the revised Amyotrophic Lateral Sclerosis Functional Ra...
There is a need of standardized and quantitative clinical assessments of ALS patients receiving new ...
Our objective was to verify and expand previous evidence of psychometric inadequacies in the ALSFRS-...
<p>Numbers are mean ± standard deviation (range) or number. °Disease progression rate = (48-ALSFRS-r...
Contains fulltext : 50613.pdf (publisher's version ) (Closed access)It is importan...
The measurement of functioning and well-being from the perspective of the patient has in recent year...
Objective: The aim of the study was to investigate the incidence and prevalence of amyotrophic later...
OBJECTIVES: To evaluate the validity and reliability of the amyotrophic lateral sclerosis assessme...
<p>Our objective was to examine dimensionality and item-level performance of the Amyotrophic Lateral...
Cognitive and behavioral impairment is observed in up to 50% of patients with amyotrophic lateral sc...